pharma

Is Lilly and Amylin's Byetta Better?

This AMLN pumping is just disgusting.

During the last 4 years company insiders received and cashed out huge amounts of granted options in spite of terrible sale or stock price performance.

AMLN has total disregard for it shareholders.

AMLN was burning money having huge expenses but their clinical trials looked more like Mickey Mouse trials with too few patients to be conclusive.

The last trial for LAR Byetta was a comparative trial with so few patients than it is impossible to make any definite conclusion regarding either Byetta or LAR Byetta efficacy.